Both in Pharmaceuticals

Rezolute, Inc. Common Stock (NV) vs Avalo Therapeutics

Over the past year RZLT returned −57.6% and AVTX returned −60.2%; their daily moves had a correlation of 0.06.

RZLT −57.6% AVTX −60.2%Growth of $1, one year, split-adjusted
MetricRZLTAVTX
Price$3.95$7.17
Market cap$382.1M$384.5M
Today−4.13%−3.63%
1 month−2.9%−52.0%
6 months+19.7%−47.7%
Year to date+67.4%−60.5%
1 year−58.6%−60.3%
Revenue growth (YoY)——
Gross margin——
Net margin——
P/E (TTM)——
Price / sales—6,517.4×
Net cash$107.8M$400.3M
Dividend yield——
Volatility (60d)59.6%114.9%
Short % of float22.5%24.6%
Next earnings——

Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).